Page last updated: 2024-08-26

arginyl-glycyl-aspartic acid and Fatty Liver

arginyl-glycyl-aspartic acid has been researched along with Fatty Liver in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's2 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Busuttil, RW; Coito, AJ; Duarte, S; Fondevila, C; Shen, XD1
Busuttil, RW; Coito, AJ; Fondevila, C; Moore, C; Shen, XD1

Other Studies

2 other study(ies) available for arginyl-glycyl-aspartic acid and Fatty Liver

ArticleYear
Cytoprotective effects of a cyclic RGD peptide in steatotic liver cold ischemia and reperfusion injury.
    American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons, 2009, Volume: 9, Issue:10

    Topics: Animals; Blotting, Western; Cold Temperature; Cytoprotection; Disease Models, Animal; Down-Regulation; Fatty Liver; Immunohistochemistry; In Situ Nick-End Labeling; Interferon-gamma; Matrix Metalloproteinase 9; Neutrophils; Nitric Oxide Synthase Type II; Oligopeptides; Rats; Reperfusion Injury; Reverse Transcriptase Polymerase Chain Reaction; Survival Rate

2009
Cyclic RGD peptides with high affinity for alpha5beta1 integrin protect genetically fat Zucker rat livers from cold ischemia/reperfusion injury.
    Transplantation proceedings, 2005, Volume: 37, Issue:4

    Topics: Animals; Fatty Liver; Integrin alpha5beta1; Male; Matrix Metalloproteinase 9; Nitric Oxide Synthase; Nitric Oxide Synthase Type II; Oligopeptides; Peptides, Cyclic; Rats; Rats, Zucker

2005